scispace - formally typeset
Open Access

BASIC—LIVER, PANCREAS, AND BILIARY TRACT Role of Scavenger Receptor A and CD36 in Diet-Induced Nonalcoholic Steatohepatitis in Hyperlipidemic Mice

Reads0
Chats0
TLDR
In this article, the authors proposed a mechanism by which Kupffer cells (KCs) take up modified cholesterol-rich lipoproteins via scavenger receptors (SRs).
Abstract
BACKGROUND & AIMS Nonalcoholic steatohepatitis (NASH) is a disorder that consists of steatosis and hepatic inflammation. It is not known why only some people with steatosis develop NASH. Recently, we identified dietary cholesterol as a factor that directly leads to hepatic inflammation and hepatic foam cell formation. We propose a mechanism by which Kupffer cells (KCs) take up modified cholesterol-rich lipoproteins via scavenger receptors (SRs). KCs thereby accumulate cholesterol, become activated, and may then trigger an inflammatory reaction. Scavenging of modified lipoproteins mainly depends on CD36 and macrophage scavenger receptor 1. METHODS To evaluate the involvement of SR-mediated uptake of modified lipoproteins by KCs in the development of diet-induced NASH, female low-density lipoprotein receptor-deficient (Ldlr(-/-)) mice were lethally irradiated and transplanted with bone marrow from Msr1(+/+)/Cd36(+/+)or Msr1(-/-)/Cd36(-/-) mice and fed a Western diet. RESULTS Macrophage and neutrophil infiltration revealed that hepatic inflammation was substantially reduced by approximately 30% in Msr1(-/-)/Cd36(-/-)-transplanted mice compared with control mice. Consistent with this, the expression levels of well-known inflammatory mediators were reduced. Apoptotis and fibrosis were less pronounced in Msr1(-/-)/Cd36(-/-)-transplanted mice, in addition to the protective phenotype of natural antibodies against oxidized low-density lipoprotein in the plasma. Surprisingly, the effect on hepatic inflammation was independent of foam cell formation. CONCLUSIONS Targeted inactivation of SR pathways reduces the hepatic inflammation and tissue destruction associated with NASH, independent of hepatic foam cell formation.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

The interaction of hepatic lipid and glucose metabolism in liver diseases

TL;DR: Novel findings related to nuclear receptor signaling in hepatic lipid and glucose uptake, storage and metabolism in the clinical context of non-alcoholic fatty liver disease, liver regeneration, and cancer are focused on.
Journal ArticleDOI

The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

TL;DR: Experimental and clinical data support a central role for macrophages in the development and progression of nonalcoholic fatty liver disease (NAFLD) and non alcoholic steatohepatitis (NASH) and studies investigating drugs that target macrophage recruitment to the liver, Macrophage polarization and their inflammatory effects as potential treatment options for patients with NASH are reviewed.
Journal ArticleDOI

Animal models of nonalcoholic fatty liver disease

TL;DR: This Review discusses the prevalent dietary and inflammation-based genetic animal models described in recent years that have been undertaken using animals to model human steatosis and NAFLD to NASH disease progression.
Journal ArticleDOI

The Role of Cholesterol in the Pathogenesis of NASH

TL;DR: This review examines the effects of excess FC in hepatocytes, Kupffer cells (KCs), and hepatic stellate cells (HSCs), and the subcellular mechanisms by which excess FC can induce cellular toxicity or proinflammatory and profibrotic effects in these cells.
Journal ArticleDOI

Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis.

TL;DR: This review focuses on cellular mechanisms of cholesterol toxicity involved in liver injury and on alterations in cholesterol homeostasis promoting hepatic cholesterol overload in NASH, and the therapeutic implications and opportunities for normalizing cellular cholesterolHomeostasis in patients.
References
More filters
Journal ArticleDOI

Inflammation and metabolic disorders

TL;DR: Dysfunction of the immune response and metabolic regulation interface can be viewed as a central homeostatic mechanism, dysfunction of which can lead to a cluster of chronic metabolic disorders, particularly obesity, type 2 diabetes and cardiovascular disease.
Journal ArticleDOI

Molecular mediators of hepatic steatosis and liver injury

TL;DR: Recent advances in the understanding of the molecular events contributing to hepatic steatosis and nonalcoholic steatohepatitis are highlighted.
Journal ArticleDOI

CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism

TL;DR: The biology of CD36 can be broadly divided in terms of functions that it mediates with or without TSP-1, but it is probable that it acts in concert with other proteins, such as fatty acid–binding proteins, caveola-associated proteins, integrins, cytoskeletal proteins, and signaling molecules, to effect its diverse functions.
Related Papers (5)